Nanoligent S.L.
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- $18M
Investors
- 7
About Nanoligent S.L.
L. operates as a biotechnology company. The company was founded by its Scientific Advisor Dr. A. Villaverde, and Scientific Advisor Dra. E. Vázquez from the Nanobiotecnology Group of the UAB; Scientific Advisor Dr. R. Mangues from the Research Institut of Hospital de Sant Pau, and Chairman Dr. M. Rodríguez. It was formed as a spinoff of the Universitat Autònoma de Barcelona (UAB) and Institut de Recerca de l’Hospital de la Santa Creu I Sant Pau.L. Nanoligent uses engineering and nanobiotechnology to create and develop nanotechnology-based medications and targeted drug therapy for the treatment of more than 20 different metastatic cancer types. As of 2022, the company's portfolio includes NNL-121, a self-assembling protein nanoparticle that targets Cancer cell receptor CXCR4 and can be utilized to treat metastatic colorectal cancer.
Who invested in Nanoligent S.L.
7 investors across 3 rounds
See all investors in Nanoligent S.L.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nanoligent S.L.
Who invested in Nanoligent S.L.?
Nanoligent S.L. has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nanoligent S.L. raised?
Nanoligent S.L. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Nanoligent S.L. last raise money?
Nanoligent S.L.'s most recent round on record is a Series A, in Sep 2025.
What does Nanoligent S.L. do?
Nanoligent S.L. is a biotechnology company.
Where is Nanoligent S.L. headquartered?
Nanoligent S.L. is headquartered in Barcelona, Spain.
Which VCs invest in companies like Nanoligent S.L.?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Nanoligent S.L.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nanoligent S.L.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.